390 related articles for article (PubMed ID: 18336627)
21. Neuromyelitis optica: effect of gender.
Wingerchuk DM
J Neurol Sci; 2009 Nov; 286(1-2):18-23. PubMed ID: 19740485
[TBL] [Abstract][Full Text] [Related]
22. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
Biochem Biophys Res Commun; 2009 Sep; 386(4):623-7. PubMed ID: 19545538
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic criteria in acute neuromyelitis].
Panea C; Petrescu S; Monica P; Voinea L; Dascălu AM; Nicolae M; Ungureanu E; Panca A; Grădinaru S
Oftalmologia; 2007; 51(4):116-20. PubMed ID: 18543687
[TBL] [Abstract][Full Text] [Related]
24. The spectrum of neuromyelitis optica (NMO) in childhood.
Tillema JM; McKeon A
J Child Neurol; 2012 Nov; 27(11):1437-47. PubMed ID: 22859697
[TBL] [Abstract][Full Text] [Related]
25. The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.
Idiman E; Ozakbaş S
Expert Rev Neurother; 2011 Mar; 11(3):451-62. PubMed ID: 21375450
[TBL] [Abstract][Full Text] [Related]
26. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
[TBL] [Abstract][Full Text] [Related]
27. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
Weinstock-Guttman B; Miller C; Yeh E; Stosic M; Umhauer M; Batra N; Munschauer F; Zivadinov R; Ramanathan M
Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816
[TBL] [Abstract][Full Text] [Related]
28. Neuromyelitis optica.
Feingold RM
J Insur Med; 2008; 40(2):136-40. PubMed ID: 19119594
[TBL] [Abstract][Full Text] [Related]
29. [Neuromyelitis optica: the disease entity, pathogenesis and therapy].
Fujihara K
Rinsho Shinkeigaku; 2007 Nov; 47(11):883-5. PubMed ID: 18210826
[TBL] [Abstract][Full Text] [Related]
30. [Recurrent inflammatory optic neuritis and neuromyelitis optica].
de Sèze J; Arndt C
Rev Neurol (Paris); 2010 Dec; 166(12):966-9. PubMed ID: 21126746
[TBL] [Abstract][Full Text] [Related]
31. Neuromyelitis optica: a new perspective.
Pittock SJ
Semin Neurol; 2008 Feb; 28(1):95-104. PubMed ID: 18256990
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis optica: concept, immunology and treatment.
Uzawa A; Mori M; Kuwabara S
J Clin Neurosci; 2014 Jan; 21(1):12-21. PubMed ID: 23916471
[TBL] [Abstract][Full Text] [Related]
33. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes.
Sellner J; Hemmer B; Mühlau M
J Autoimmun; 2010 Jun; 34(4):371-9. PubMed ID: 19853412
[TBL] [Abstract][Full Text] [Related]
34. Glatiramer acetate could be a hypothetical therapeutic agent for neuromyelitis optica.
Wang KC; Lee CL; Chen SY; Lin KH; Tsai CP
Med Hypotheses; 2011 Jun; 76(6):820-2. PubMed ID: 21398045
[TBL] [Abstract][Full Text] [Related]
35. Neuromyelitis optica preceded by brain demyelinating episode.
Amemiya S; Hamamoto M; Kumagai T; Ueda M; Katayama Y; Tanaka K
J Neuroimaging; 2009 Jul; 19(3):263-5. PubMed ID: 18681925
[TBL] [Abstract][Full Text] [Related]
36. Down's syndrome and neuromyelitis optica (Devic's disease). An autopsy-proven case.
Cabrera-Gómez JA; Galarraga-Inza J; Coro-Antich RM; Real-González Y; Cristofol-Corominas M; Gómez H; Romero-Garcia K; Gil-Gil MX; Gonzalez-Quevedo A
Mult Scler; 2007 Apr; 13(3):433-6. PubMed ID: 17439915
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review.
Pereira WL; Reiche EM; Kallaur AP; Kaimen-Maciel DR
J Neurol Sci; 2015 Aug; 355(1-2):7-17. PubMed ID: 26050520
[TBL] [Abstract][Full Text] [Related]
38. Neurological autoimmunity targeting aquaporin-4.
Hinson SR; McKeon A; Lennon VA
Neuroscience; 2010 Jul; 168(4):1009-18. PubMed ID: 19699271
[TBL] [Abstract][Full Text] [Related]
39. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica.
Chan KH; Tsang KL; Fong GC; Cheung RT; Ho SL
Clin Neurol Neurosurg; 2005 Feb; 107(2):132-5. PubMed ID: 15708229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
